PMID: 11335908May 4, 2001Paper

Burden of illness associated with metastatic melanoma: an audit of 100 consecutive referral center cases

Cancer
B E HillnerS S Agarwala

Abstract

Although long-term survival in patients with metastatic melanoma (MM) is infrequent, response to a variety of cytotoxic and immunotherapies occurs and survival varies based on the site of metastases. Because different patterns of care of MM are likely to vary substantially in their intensity and resource use, the authors audited care at a regional referral center. The records of 100 consecutive new patients with MM who presented at the University of Pittsburgh Cancer Institute (UPCI) after January 1997 were audited. Demographics, disease sites, and treatment prior to presentation at UPCI as well as the diagnostic and therapeutic methods undertaken at UPCI were tracked monthly with regard to inpatient and outpatient activity. The median age of the patient cohort was 51 years was a median 2.2 years after the time of initial diagnosis. Eighty-two percent of the patients had died and only 8% had been lost to long-term follow-up. Eighty-seven percent of patients had been referred to UPCI and 28% had received some treatment prior to presenting at UPCI. The median survival was 9.0 months. The lung was the most common symptomatic site and 38% of patients developed central nervous system (CNS) metastases. Eighty-four percent of patients...Continue Reading

References

Mar 15, 1995·Journal of the National Cancer Institute·S H TaplinP Nefcy
Jan 1, 1997·Annual Review of Public Health·J S Preisser, G G Koch
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B E HillnerT J Smith
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B E HillnerS M Retchin
Jul 8, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C C EarleW K Evans
Mar 29, 2000·CA: a Cancer Journal for Clinicians·R T GreenleeP A Wingo
Nov 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J ManolaJ Kirkwood

❮ Previous
Next ❯

Citations

Jul 24, 2008·Journal of Cancer Survivorship : Research and Practice·Susan A OliveriaAllan C Halpern
Oct 30, 2007·Nature Clinical Practice. Oncology·K Robin YabroffMartin L Brown
Aug 8, 2007·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A B FranckenJ F Thompson
Apr 18, 2015·Melanoma Research·Chun-Lan ChangYeun Mi Yim
Sep 29, 2004·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·R CrottS Burdette-Radoux
Oct 20, 2012·American Journal of Preventive Medicine·Gery P GuyLisa C Richardson
Jan 30, 2008·Melanoma Research·Julie ChevalierMarie-Françoise Avril
Jun 30, 2009·Applied Health Economics and Health Policy·Keith L DavisJedd D Wolchok
Dec 17, 2017·Journal of Pain and Symptom Management·Rebecca N HutchinsonKathleen M Fairfield

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the National Cancer Institute
K Robin YabroffMartin L Brown
International Journal of Technology Assessment in Health Care
Gunnar H NilssonHenrik Ullén
Tijdschrift voor gerontologie en geriatrie
Archives of Dermatology
Daniel G FedermanRobert S Kirsner
© 2021 Meta ULC. All rights reserved